Ardent Health Partners, LLC (NYSE:ARDT) Receives Consensus Rating of “Buy” from Analysts

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have been given a consensus rating of “Buy” by the twelve brokerages that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $21.18.

A number of brokerages recently issued reports on ARDT. Royal Bank of Canada dropped their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Stephens restated an “overweight” rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research report on Thursday, February 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Finally, Truist Financial decreased their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, January 6th.

Ardent Health Partners Price Performance

NYSE ARDT opened at $13.30 on Tuesday. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a 52 week low of $13.07 and a 52 week high of $20.72. The firm’s 50-day simple moving average is $14.47 and its two-hundred day simple moving average is $16.37.

Ardent Health Partners (NYSE:ARDT) last issued its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. Research analysts predict that Ardent Health Partners will post 1.23 EPS for the current year.

Institutional Trading of Ardent Health Partners

A number of hedge funds have recently bought and sold shares of ARDT. State Street Corp purchased a new position in shares of Ardent Health Partners during the third quarter worth approximately $1,977,000. Jane Street Group LLC purchased a new position in Ardent Health Partners in the 3rd quarter worth $567,000. Goldentree Asset Management LP bought a new stake in Ardent Health Partners in the third quarter worth $22,897,000. Barclays PLC purchased a new stake in Ardent Health Partners during the third quarter valued at about $385,000. Finally, Geode Capital Management LLC bought a new position in shares of Ardent Health Partners during the third quarter valued at about $2,581,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.